Medical Group Expects FTC Action on Transgender Procedures for Minors
Do No Harm has submitted comments to the Federal Trade Commission's public inquiry, disputing the safety and effectiveness of gender-affirming care for minors.
Do No Harm told FTC it disputes that gender-affirming care for minors is safe, effective, and “reduces the risk of suicide.”
According to Dr. Kurt Miceli, medical director of Do No Harm, the group expects the FTC to take action to protect children from "unsafe and unproven sex change interventions".
- Do No Harm has submitted comments to the FTC's public inquiry on the child transgender industry.
- The group disputes the safety and effectiveness of gender-affirming care for minors.
- Dr. Kurt Miceli expects the FTC to take meaningful action to protect vulnerable children.
Author's summary: Medical group expects FTC action on transgender procedures.